Technical Analysis for ABIO - ARCA biopharma, Inc.

Grade Last Price % Change Price Change
grade F 0.41 0.00% 0.00
ABIO closed unchanged on Wednesday, January 16, 2019, on 15 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
15 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ABIO trend table...

Date Alert Name Type % Chg
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 16 Weak + Overbought Other 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 15 Stochastic Reached Overbought Strength 0.00%
Jan 15 Weak + Overbought Other 0.00%
Jan 15 Wide Bands Range Expansion 0.00%
Jan 15 Overbought Stochastic Strength 0.00%
Jan 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%

Older signals for ABIO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Is ABIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 16 Zosano Appoints Linda Grais M.D., J.D. to Board of Directors
Dec 28 The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO
Dec 27 The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede
Dec 26 ARCA biopharma, Inc. (NASDAQ:ABIO) Insiders Have Been Selling
Dec 21 The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Dec 20 ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
Nov 15 34 Stocks Moving In Thursday's Pre-Market Session
Nov 14 ARCA biopharma reports Q3 results
Nov 14 ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update
Nov 12 GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions
See more ABIO news...
Indicators
Indicator Value
52 Week High 1.95
52 Week Low 0.26
Average Volume 340,550
200-Day Moving Average 0.5615
50-Day Moving Average 0.5015
20-Day Moving Average 0.362
10-Day Moving Average 0.3845
Average True Range 0.0438
ADX 20.68
+DI 18.5857
-DI 16.3645
Chandelier Exit (Long, 3 ATRs ) 0.3986
Chandelier Exit (Short, 3 ATRs ) 0.3914
Upper Bollinger Band 0.4681
Lower Bollinger Band 0.2559
Percent B (%b) 0.73
BandWidth 58.618785
MACD Line -0.022
MACD Signal Line -0.0382
MACD Histogram 0.0162
Fundamentals Value
Market Cap 4.82 Million
Num Shares 11.7 Million
EPS -2.05
Price-to-Earnings (P/E) Ratio -0.20
Price-to-Sales 0.00
Price-to-Book 0.92
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.46
Resistance 3 (R3) 0.45 0.43 0.45
Resistance 2 (R2) 0.43 0.42 0.43 0.44
Resistance 1 (R1) 0.42 0.41 0.43 0.43 0.44
Pivot Point 0.40 0.40 0.40 0.40 0.40
Support 1 (S1) 0.39 0.39 0.40 0.40 0.38
Support 2 (S2) 0.37 0.38 0.37 0.38
Support 3 (S3) 0.36 0.37 0.37
Support 4 (S4) 0.37